The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey

Anaerobe

Volumn 35, Issue , 2015, Pages 72-76

  Kangaba, Achille Aime ^a   Saglam, Filiz Yarimcam ^b   Tokman, Hrisi Bahar ^a   Torun, Mert ^b   Torun, Muzeyyen Mamal ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

Bacteroides fragilis group; Bft; CepA; CfiA; ErmF; Nim; TetQ

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOXITIN; CLINDAMYCIN; ENTEROTOXIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; FRAGILYSIN; METALLOPROTEINASE;

ABDOMINAL ABSCESS; ABSCESS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPIRATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BARTOLINI ABSCESS; BFT GENE; CEPA GENE; CFIA GENE; CHILD; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ERMF GENE; FEMALE; GASTROINTESTINAL TRACT; GENETICS; HUMAN; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NIM GENE; NONHUMAN; PARABACTEROIDES DISTASONIS; PELVIS ABSCESS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECTAL ABSCESS; SCHOOL CHILD; SKIN INJURY; SPECIES CULTIVATION; TETQ GENE; TURKEY (REPUBLIC); BACTEROIDES INFECTIONS; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TURKEY;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; DRUG RESISTANCE, BACTERIAL; ENTEROTOXINS; FEMALE; GENES, BACTERIAL; HUMANS; MALE; METALLOENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; TURKEY;

EID: 84938310742     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.07.008     Document Type: Article

References (34)

1. Wexler H.M. Bacteroides: the good, the bad and the nitty-gritty. Clin. Microbiol. Rev. 2007, 163:51-56.
2. Finegold S.M. Anaerobic Bacteria in Human Disease 1977, Academic Press, New York. first ed.
3. Goldstein E.J.C., Citron D.M. Resistance trends in antimicrobial susceptibility of anaerobic bacteria, part I. Clin. Microbiol. Newsl. 2011, 33:1-8.
4. Goldstein E.J.C., Citron D.M., Goldman P.J. National hospital survey of anaerobic culture and susceptibility methods: III. Anaerobe 2008, 14:68-72.
5. Jamal W., Hashem G.A., Rotimi V.O. Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comperative analysis of 11 year data. Anaerobe 2015, 31:25-30.
6. Fille M., Mango M., Lechner M., Schaumann R. Bacteroides fragilis group: trends in resistance. Curr. Microbiol. 2006, 52:153-157.
7. Marchan-Austin A., Rawte P., Toye B., Jamieson F.B. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011. Anaerobe 2014, 28:120-125.
8. Nagy E., Urban E., Nord C.E. Antimicrobic susceptibility of Bacteroides fragilis group isolates in Europe: 20 year experience. Clin. Microbiol. Infect. Dis. CMT 2011, 17:371-379. on behalf of the ESCMID Study group on Antimicrobial resistance in anaerobic bacteria.
9. Smith C.J., Tribble G.D., Bayley D.P. Genetic elements of Bacteroides species: a moving story. Plasmid 1998, 40:12-29.
10. Sears C.L., Islam S., Saha A., Arjumand M., Alam N.H., Faruque A.S.G., et al. Association of enterotoxigenic Bacteroides fragilis infection with inflamatory diarrhea. Clin. Infect. Dis. 2008, 47:797-803.
11. Garret W.G., Onderdone A.B. Bacteroides, Prevotella, Porphyromonas and Fusobacterium and other Medically important anaerobic gram negative Bacilli. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Disease 2010, 3111-3120. seventh ed. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
12. Akpinar M., Aktaş E., Cömert F., Sümbüloglu V. Evaluation of the prevalence of enterotoxigenic Bacteroides fragilis and the distribution of bft gene subtypes in patients with diarrhea. Anaerobe 2010, 16:505-509.
13. Ramamurthy D., Pazhani G.P., Sarkar A., Nandy R.K., Rajendran K., Sur D. Case-control study on the role of enterotoxigenic B.fragilis as a cause of diarrhea among children in Kalkata, India. PLoS One 2013, 8:1-7.
14. Kato N., Liu S., Kato H., Watanabe K., Nakamura H., Iwai N. Prevalence of enterotoxigenic of Bacteroides fragilis in children with diarrhea in Japan. J.Clin. Microbiol. 1999, 37:801-803.
15. Zhang G., Svenungsson B., Kornell A., Weintraub A. Prevalance of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. Clin. Infect. Dis. 1999, 29:590-594.
16. Toprak U.V., Yagci A., Gulluoglu B.M., Akin M.L., Demirkalem P., Celenk T., Soyletir G. Apossible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 2006, 12:782-786.
17. Koneman E.W., Allen S.D., Janda W.M., Schereckenberger B.C., Winn W.C. Color Atlas and Textbook of Diagnostic Microbiology 2006, 124-146. Lippincott Publishing, Philadelphia. sixth ed.
18. Clinical and Laboratory Standards Institite (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement M100-523 2013, Clinical and Laboratory Standards Institute, Wayne, Pensylvania.
19. Pumbwe L., Curzon M., Wexler H.M. Rapid multiplex PCR assay for simultanous detection of major antibiotic resistance determinants in clinical isolates of Bacteroides fragilis. J.Rapid Meth Aut. Mic. 2008, 16:381-393.
20. Soki J., Gonzalez S.M., Urban E., Nagy E., Ayala J.A. Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. J.Antimicrob. Chemother. 2011, 66:2492-2500.
21. Nakano V., Avila-Campos M.J. Virulence Markers and Antimicrobial Susceptibility of Bacteria of Bacteroides Fragilis Group Isolated from Stool of Children with Diarrhea in Sao Paolo, Brazil 2014, vol. 99:307-312. Mem Inst Oswald Cruz, Rio de Janeiro.
22. Ulger U.N., Aral C., Ilki A., Ozer A., Soyletir G. Investigation of phenotipical and genotypical characteristics of the first imipenem resistant B.fragilis isolated in Marmara University Medical Faculty Hospital. Flora 2009, 14:175-181.
23. Nagy E. Anaerobic Infections: update on treatment considerations. Drugs 2010, 70:841-858.
24. Tran C.M., Tanaka K. PCR- based detection of resistance genes in aerobic bacteria isolated from intra-abdominal infections. J.Infect. Chemother. 2013, 19:279-290.
25. Toprak U.N., Uzunkaya O.D., Soki J., Soyletir G. Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in Turkish University Hospital. Anaerobe 2012, 18:168-171.
26. Soki J., Eitel Z., Urban E., Nagy E. Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int. J. Antimicrob. Agents 2013, 41:122-125. on behalf of Escmid Study Group on Anaerobic Infections.
27. Eitel Z., Sóki J., Urbán E., Nagy E. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe 2013, 21:43-49. on behalf of ESCMID Study Group on Anaerobic Infection.
28. Karlowsky J.A., Walkty A.J., Adam H.J., Baxter M.R., Hoban D.J., Zhanel G.G. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis Group in Canada 2010-2011:CANWAPD Surveillance Study. Antimicrob. Agents Chemother. 2012, 56:1247-1252.
29. Wang J., Shoemaker N., Wang G.P., Salyers A.A. Characterization of Bacteroides mobilizable transposon, NBU2, which carries a functional lincomycin resistance. J.Bacteriol. 2000, 182:3539-3541.
30. Haggoud A., Reysset B., Azeddoug H., Sebald M. Nucleotide sequence analysis of two 5'-nitromidazole resistance determinants from Bacteroides strains anf of a new insertion sequence upstream of the two genes. Antimicrob. Agents Chemother. 1994, 38:1047-1051.
31. Reysset G., Haggould A., Su W., Sebald M. Genetic and molecular analysis of pIP417 and pIP419: Bacteroides plasmids encoding 5-nitroimidazole resistance. Plasmid 1992, 27:181-190.
32. Narikawa S., Suzuki T., Yamamoto M., Nakamura M. Lactate dehydrogenase activity as a cause of metronidazole resistance Bacteroides fragilis NCTC 11295. J.Antimicrob. Chemother. 1991, 28:47-53.
33. Diniz C.G., Farias L.M., Carvalho M.A.R., Rocha E.R., Smith C.J. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutatnt. J.Antimicrob. Chemother. 2004, 54:100-108.
34. Patel E.H., Paul L.V., Csanueva A.I., Patrick S., Abiatt V.R. Overexpression of rhamnoz catabolism regulatiin protein RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotamicron. Antimicrob. Chemother. 2009, 69:267-273.